Monday, April 8, 2019 (HealthDay News) – Experts hear the warning of a basket of four patients in New York City cities, including "superbug" of god " t E.coli attack.
E. coli has anti-antibiotic reproductions called mcr-1 that are taken by patients. .
In addition, three of the four patients did not have symptoms of E. coli – highlighting the danger of potentially spreading antibiotics to people without knowing that, Uhlemann and cargos told people that they April 8th April in the journal Antimicrobial and chemotherapy agents.
"The description of mercury from other parts of the world has been minimal in U .." Uhlemann said in a press release. T But the new report highlights the opportunities for the spread of non-drug E. E. coli in NHS hospitals. T Uhlemann is a joint professor at the University of Columbia's College of Physicians and Surgeons.
One emergency pharmacist said it was not part of the investigation that he is being worried about the news.
"The mc-1 gene provides an attack for colistin, one of the antibiotics for final treatment of negative infection," said Dr Robert Glatter, who works at Lenox Hill Hospital. project in New York City.
The gene is now found not only E. coli but inward Salmonella, Klebsiella and different subtitles Entranceer bacteria. In fact, this gene has been found in bacteria in more than 30 countries in five continents since 2017, "he said.
A genetic order showed that all E. coli bacteria in each patient were closely linked but were not identical.
“Then we reviewed everyone's clinical course and noted the first patient had a disease, but the other three had just carried the bacteria in their feces,” Uhlemann said.
In these latter cases, "one of these three patients has not suffered disease with these bacteria," she said.
The survey was prompted by concerns about an increase in an antibiotic rate, a growing threat. According to researchers, scientists believe that antibiotic disorders could cause more cancer deaths by 2050.
According to Glatter, the ability of dispersed distribution of bacteria with mcr-1 to be "a huge threat to people's lives if we cannot discharge it." He believes the new report "awakes from the continuing risk of antibiotic protection for human health."
The new results represent the collection of health care related enrollments in the United States, which were recorded earlier in the United States, and before a recent poll in 2017 introduced Uhlemann fa. face.
Excessive use of antibiotics in healthcare and agriculture contributes to the problem of antibiotic resistance, "how germs learn about working around the life saving drugs, Glatter said.
Too much use can happen when patients, and doctors provide, antibiotics for viral infection such as flu, for example. Drugs are only effective against bacteria, not viruses.
The UHI Direct Centers for the Prevention of Disease Control and Prevention are further affected.
SOURCES: Robert Glatter, M.D., emergency doctor, Lenox Hill Hospital, New York City; Antimicrobial and chemotherapy agents, press release, April 8, 2019